🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "focused steps to tackle cost of living issues" in next month's Budget.

In comments to media outlets, she emphasized that reducing inflation is a collective task of both the government and the Bank of England.

The UK's price growth is expected to be the highest among the Group of Seven developed nations this calendar year and next.

Potential Utility Cost Interventions

Reports indicate the government could take action to reduce utility costs, for example by cutting the present 5% level of value-added tax charged on energy supplies.

A further approach is to lower some of the government charges presently included in household expenses.

Budgetary Limitations and Expert Expectations

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for such measures.

The view from most analysts is that Reeves will have to introduce higher taxes or expenditure reductions in order to adhere to her voluntary borrowing rules.

Earlier on the same day, calculations suggested there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the lower end of expectations.

"There's a joint task between the Bank of England and the government to further reduce some of the causes of inflation," the Chancellor stated to the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Issues

While much of the attention has been on probable tax increases, the Treasury chief said the latest data from the fiscal watchdog had not changed her vow to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing geopolitical and commercial tensions for the fiscal tax moves, likely to be focused on those "most able to pay."

Global Economic Disputes

Commenting on apprehensions about the UK's commercial links with China she said: "Our security interests invariably come first."

Recent announcement by Chinese authorities to tighten export controls on critical minerals and other materials that are key for advanced tech production led American leader the US President to threaten an additional 100% tariff on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the US offer to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "bad for the world economy and creates additional challenges."

"It is my opinion there are sectors where we must address Chinese policies, but there are also important prospects to trade with China's economy, including financial services and other sectors of the economy. We've got to maintain that balance correct."

The chancellor also confirmed she was collaborating with other major economies "on our own essential resources plan, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also recognized that the price the NHS pays for pharmaceuticals could increase as a result of current talks with the Trump administration and its drugs companies, in return for reduced taxes and funding.

Some of the world's largest drug companies have said recently that they are either halting or abandoning operations in the UK, with several blaming the modest returns they are getting.

Last month, the Science Minister said the price the NHS spends on drugs would have to go up to stop businesses and pharmaceutical investment departing from the UK.

The Chancellor told media: "We have seen as a result of the cost structure, that clinical trials, new drugs have not been offered in the UK in the way that they are in other European countries."

"The objective is to guarantee that people getting treatment from the NHS are can access the top life-saving medicines in the globe. And so we are examining this situation, and... aiming to attract increased funding into Britain."